Blocking two cancer pathways may curb medulloblastoma relapse, preclinical study suggests

Dr. Jezabel Rodriguez Blanco’s research looks at repurposing a drug that already has FDA approval and using it instead to address relapse in medulloblastoma. Credit: Clif…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *